IS:JUBLPHARMA Jubilant Pharmova Limited

Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is headquartered in Noida, India.

570.05 INR
As of 01/17/2022

Security Information
Category1:  Global Equity
Category2:  Comon stocks
Category3:  Emerging markets
GICS sector:  Health Care
Index country:  India
Country of incorporation:  
IPO date:  11/09/1994
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   91,061,256,192 INR
Current dividend yield:   0.88%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy